Lamivudine is safe and effective in fulminant hepatitis B

被引：26

作者：

Santantonio, T ^{[1
]}

Mazzola, M ^{[1
]}

Pastore, G ^{[1
]}

机构：

[1] Univ Bari, Clin Malattie Infett, I-70121 Bari, Italy

来源：

JOURNAL OF HEPATOLOGY | 1999年 / 30卷 / 03期

关键词：

D O I：

10.1016/S0168-8278(99)80119-6

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：551 / 551

页数：1

共 3 条

[1] Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation [J].

Bartholomew, MM ;

Jansen, RW ;

Jeffers, LJ ;

Reddy, KR ;

Johnson, LC ;

Bunzendahl, H ;

Condreay, LD ;

Tzakis, AG ;

Schiff, ER ;

Brown, NA .

LANCET, 1997, 349 (9044) :20-22

[2] Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo-controlled trial [J].

Lai, CL ;

Ching, CK ;

Tung, AKM ;

Li, E ;

Young, J ;

Hill, A ;

Wong, BCY ;

Dent, J ;

Wu, PC .

HEPATOLOGY, 1997, 25 (01) :241-244

[3] Dynamics of hepatitis B virus infection in vivo [J].

Zeuzem, S ;

deMan, RA ;

Honkoop, P ;

Roth, WK ;

Schalm, SW ;

Schmidt, JM .

JOURNAL OF HEPATOLOGY, 1997, 27 (03) :431-436

← 1 →